The absence of meaningful P/E or EV/EBITDA multiples reflects a company currently devoid of sustainable earnings, forcing investors to rely on price-to-sales metrics that may be distorted by the transition to a joint-venture model. This valuation approach warrants extreme caution, as the current market capitalization may be overestimating the speed at which royalty streams or equity-accounted income can replace lost manufacturing revenue.

The gross margin of 17.8% suggests that the company struggles to achieve the economies of scale necessary to cover its fixed R&D costs, which are essential for maintaining its proprietary technology. Investors should monitor whether the shift toward a joint-venture structure can successfully offload these high fixed costs, as the current margin profile indicates a business model that is not yet self-sustaining.

The persistent negative ROIC suggests that the capital deployed into HPDI development has not yet translated into a competitive advantage that yields economic profit. This trend warrants further investigation into whether the company's pivot to an asset-light model will eventually improve capital efficiency or if the underlying technology remains too capital-intensive for the current market size.

The volatility in DSO and DIO metrics suggests that the company's operational efficiency is currently hostage to the timing of project-based OEM contracts and the liquidation of legacy inventory. This lack of predictability in the cash conversion cycle complicates the assessment of the company's ability to manage its short-term obligations without further external financing.